Literature DB >> 19197151

Strong inducible knockdown of APC/CCdc20 does not cause mitotic arrest in human somatic cells.

Axel J Baumgarten1, Julia Felthaus, Ralph Wäsch.   

Abstract

The anaphase-promoting complex/cyclosome (APC/C) is a conserved ubiquitin ligase controlling mitosis and G1 phase of the cell cycle. The APC/C is activated by two regulatory subunits Cdc20 (APC/C(Cdc20)) and Cdh1 (APC/C(Cdh1)) to target securin, mitotic cyclins and other cell cycle regulatory proteins. Cdc20 is essential for sister chromatid separation at the meta- to anaphase transition in yeast, drosophila and perhaps mouse embryos. However, whether Cdc20 is essential for mitotic control of human somatic cells is uncertain. Therefore, we used a lentiviral vector-mediated inducible RNA interference (RNAi) system to generate strong downregulation of Cdc20 expression in clonal cells to further elucidate the role of human Cdc20. Here we show, that even an almost complete knockdown of Cdc20 below the detection limit in western blots does neither cause a mitotic block nor significant stabilization of the APC/C(Cdc20) substrates cyclin B and securin. Thus, there may be redundant mechanisms of mitotic control in the human somatic cell cycle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19197151     DOI: 10.4161/cc.8.4.7810

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  9 in total

Review 1.  Cubism and the cell cycle: the many faces of the APC/C.

Authors:  Jonathon Pines
Journal:  Nat Rev Mol Cell Biol       Date:  2011-06-02       Impact factor: 94.444

2.  Inhibitory phosphorylation of cyclin-dependent kinase 1 as a compensatory mechanism for mitosis exit.

Authors:  Jeremy P H Chow; Randy Y C Poon; Hoi Tang Ma
Journal:  Mol Cell Biol       Date:  2011-01-24       Impact factor: 4.272

3.  Genome-wide microarray evidence that 8-cell human blastomeres over-express cell cycle drivers and under-express checkpoints.

Authors:  Ann A Kiessling; Ritsa Bletsa; Bryan Desmarais; Christina Mara; Kostas Kallianidis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2010-04-01       Impact factor: 3.412

Review 4.  Cdc20: a potential novel therapeutic target for cancer treatment.

Authors:  Zhiwei Wang; Lixin Wan; Jiateng Zhong; Hiroyuki Inuzuka; Pengda Liu; Fazlul H Sarkar; Wenyi Wei
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Identification of a physiological E2 module for the human anaphase-promoting complex.

Authors:  Adam Williamson; Katherine E Wickliffe; Barbara G Mellone; Ling Song; Gary H Karpen; Michael Rape
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

6.  Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly.

Authors:  Hsiao-Chun Huang; Jue Shi; James D Orth; Timothy J Mitchison
Journal:  Cancer Cell       Date:  2009-10-06       Impact factor: 31.743

7.  The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell Carcinoma.

Authors:  Angela McHugh; Kenneth Fernandes; Nerime Chinner; Adel F M Ibrahim; Amit K Garg; Garry Boag; Lydia A Hepburn; Charlotte M Proby; Irene M Leigh; Mark K Saville
Journal:  J Invest Dermatol       Date:  2019-11-06       Impact factor: 8.551

8.  R383C mutation of human CDC20 results in idiopathic non-obstructive azoospermia.

Authors:  Lingwei Li; Liqing Fan; Nanni Peng; Lihua Yang; Lisha Mou; Weiren Huang
Journal:  Oncotarget       Date:  2017-09-16

9.  Paradoxical mitotic exit induced by a small molecule inhibitor of APC/CCdc20.

Authors:  Katherine V Richeson; Tatyana Bodrug; Katharine L Sackton; Masaya Yamaguchi; Joao A Paulo; Steven P Gygi; Brenda A Schulman; Nicholas G Brown; Randall W King
Journal:  Nat Chem Biol       Date:  2020-03-09       Impact factor: 15.040

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.